Allosteric nanobodies to study the interactions between SOS1 and RAS

Protein-protein interactions (PPIs) are central in cell metabolism but research tools for the structural and functional characterization of these PPIs are often missing. Here we introduce broadly applicable immunization ( C ross-link PPIs and i mmunize ll amas, ChILL) and selection strategies ( Dis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature communications 2024-07, Vol.15 (1), p.6214-10, Article 6214
Hauptverfasser: Fischer, Baptiste, Uchański, Tomasz, Sheryazdanova, Aidana, Gonzalez, Simon, Volkov, Alexander N., Brosens, Elke, Zögg, Thomas, Kalichuk, Valentina, Ballet, Steven, Versées, Wim, Sablina, Anna A., Pardon, Els, Wohlkönig, Alexandre, Steyaert, Jan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Protein-protein interactions (PPIs) are central in cell metabolism but research tools for the structural and functional characterization of these PPIs are often missing. Here we introduce broadly applicable immunization ( C ross-link PPIs and i mmunize ll amas, ChILL) and selection strategies ( Dis play and co -selection, DisCO) for the discovery of diverse nanobodies that either stabilize or disrupt PPIs in a single experiment. We apply ChILL and DisCO to identify competitive, connective, or fully allosteric nanobodies that inhibit or facilitate the formation of the SOS1•RAS complex and modulate the nucleotide exchange rate on this pivotal GTPase in vitro as well as RAS signalling in cellulo . One of these connective nanobodies fills a cavity that was previously identified as the binding pocket for a series of therapeutic lead compounds. The long complementarity-determining region (CDR3) that penetrates this binding pocket serves as pharmacophore for extending the repertoire of potential leads. Protein-protein interactions are central in cell metabolism but research tools for their characterization are missing. Here, the authors introduce strategies for the discovery of nanobodies that modulate the SOS1•RAS complex formation.
ISSN:2041-1723
2041-1723
DOI:10.1038/s41467-024-50349-2